Literature DB >> 20541611

Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism.

Markus Donix1, Alison C Burggren, Nanthia A Suthana, Prabha Siddarth, Arne D Ekstrom, Allison K Krupa, Michael Jones, Anup Rao, Laurel Martin-Harris, Linda M Ercoli, Karen J Miller, Gary W Small, Susan Y Bookheimer.   

Abstract

People with the apolipoprotein-Eepsilon4 (APOE-4) genetic risk for Alzheimer's disease show morphologic differences in medial temporal lobe regions when compared to non-carriers of the allele. Using a high-resolution MRI and cortical unfolding approach, our aim was to determine the rate of cortical thinning among medial temporal lobe subregions over the course of 2 years. We hypothesized that APOE-4 genetic risk would contribute to longitudinal cortical thickness change in the subiculum and entorhinal cortex, regions preferentially susceptible to Alzheimer's disease related pathology. Thirty-two cognitively intact subjects, mean age 61 years, 16 APOE-4 carriers, 16 non-carriers, underwent baseline and follow-up MRI scans. Over this relatively brief interval, we found significantly greater cortical thinning in the subiculum and entorhinal cortex of APOE-4 carriers when compared to non-carriers of the allele. Average cortical thinning across all medial temporal lobe subregions combined was also significantly greater for APOE-4 carriers. This finding is consistent with the hypothesis that carrying the APOE-4 allele renders subjects at a higher risk for developing Alzheimer's disease. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541611      PMCID: PMC3118546          DOI: 10.1016/j.neuroimage.2010.06.009

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  44 in total

1.  Retinotopic organization in human visual cortex and the spatial precision of functional MRI.

Authors:  S A Engel; G H Glover; B A Wandell
Journal:  Cereb Cortex       Date:  1997-03       Impact factor: 5.357

2.  Family history of Alzheimer's disease and hippocampal structure in healthy people.

Authors:  Markus Donix; Alison C Burggren; Nanthia A Suthana; Prabha Siddarth; Arne D Ekstrom; Allison K Krupa; Michael Jones; Laurel Martin-Harris; Linda M Ercoli; Karen J Miller; Gary W Small; Susan Y Bookheimer
Journal:  Am J Psychiatry       Date:  2010-08-04       Impact factor: 18.112

3.  In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease.

Authors:  M J de Leon; A Convit; A E George; J Golomb; S de Santi; C Tarshish; H Rusinek; M Bobinski; C Ince; D Miller; H Wisniewski
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

4.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

Authors:  T G Ohm; H Müller; H Braak; J Bohl
Journal:  Neuroscience       Date:  1995-01       Impact factor: 3.590

5.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

6.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.

Authors:  G W Small; L M Ercoli; D H Silverman; S C Huang; S Komo; S Y Bookheimer; H Lavretsky; K Miller; P Siddarth; N L Rasgon; J C Mazziotta; S Saxena; H M Wu; M S Mega; J L Cummings; A M Saunders; M A Pericak-Vance; A D Roses; J R Barrio; M E Phelps
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 7.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; S C Waring; E G Tangalos; G E Smith; R J Ivnik; S N Thibodeau; E Kokmen
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

8.  Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease.

Authors:  Nanthia A Suthana; Allison Krupa; Markus Donix; Alison Burggren; Arne D Ekstrom; Michael Jones; Linda M Ercoli; Karen J Miller; Prabha Siddarth; Gary W Small; Susan Y Bookheimer
Journal:  Neuroimage       Date:  2009-12-18       Impact factor: 6.556

9.  Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.

Authors:  Eric M Reiman; Kewei Chen; Xiaofen Liu; Daniel Bandy; Meixiang Yu; Wendy Lee; Napatkamon Ayutyanont; Jennifer Keppler; Stephanie A Reeder; Jessica B S Langbaum; Gene E Alexander; William E Klunk; Chester A Mathis; Julie C Price; Howard J Aizenstein; Steven T DeKosky; Richard J Caselli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-03       Impact factor: 11.205

10.  Correlation between BOLD fMRI and theta-band local field potentials in the human hippocampal area.

Authors:  Arne Ekstrom; Nanthia Suthana; David Millett; Itzhak Fried; Susan Bookheimer
Journal:  J Neurophysiol       Date:  2009-02-25       Impact factor: 2.714

View more
  38 in total

Review 1.  Episodic memory on the path to Alzheimer's disease.

Authors:  Michela Gallagher; Ming Teng Koh
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

2.  Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI.

Authors:  Sandhitsu R Das; Brian B Avants; John Pluta; Hongzhi Wang; Jung W Suh; Michael W Weiner; Susanne G Mueller; Paul A Yushkevich
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

Review 3.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

4.  Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yi Lu; Mei-Cheng Wang; Ola Selnes; Marilyn Albert; Timothy Brown; J Tilak Ratnanather; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

5.  Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Authors:  Pamela M Greenwood; Thomas Espeseth; Ming-Kuan Lin; Ivar Reinvang; Raja Parasuraman
Journal:  Scand J Psychol       Date:  2014-06

6.  Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: impact on memory function and metabolic networks.

Authors:  Mira Didic; Olivier Felician; Natalina Gour; Rafaelle Bernard; Christophe Pécheux; Olivier Mundler; Mathieu Ceccaldi; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-22       Impact factor: 9.236

7.  APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.

Authors:  Geoffrey A Kerchner; Daniela Berdnik; Jadon C Shen; Jeffrey D Bernstein; Michelle C Fenesy; Gayle K Deutsch; Tony Wyss-Coray; Brian K Rutt
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

8.  APOEε4 Genotype and Hypertension Modify 8-year Cortical Thinning: Five Occasion Evidence from the Seattle Longitudinal Study.

Authors:  Philippe Rast; Kristen M Kennedy; Karen M Rodrigue; Paul R A W Robinson; Alden L Gross; Donald G McLaren; Tom Grabowski; K Warner Schaie; Sherry L Willis
Journal:  Cereb Cortex       Date:  2018-06-01       Impact factor: 5.357

9.  Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.

Authors:  Alison C Burggren; Zanjbeel Mahmood; Theresa M Harrison; Prabha Siddarth; Karen J Miller; Gary W Small; David A Merrill; Susan Y Bookheimer
Journal:  Alzheimers Dement       Date:  2017-02-07       Impact factor: 21.566

10.  Anxiety and verbal memory performance in APOE-4 carriers and noncarriers aged 50 years and above.

Authors:  Ashley R Curiel; Karen J Miller; Karen Pollard; Jeanne Kim; Jena Kravitz; Gary W Small
Journal:  Aging health       Date:  2012-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.